A detailed history of Oppenheimer & CO Inc transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 17,871 shares of PRME stock, worth $59,867. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,871
Previous 21,031 15.03%
Holding current value
$59,867
Previous $108,000 36.11%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$3.41 - $6.7 $10,775 - $21,172
-3,160 Reduced 15.03%
17,871 $69,000
Q2 2024

Aug 07, 2024

BUY
$4.3 - $8.03 $3,676 - $6,865
855 Added 4.24%
21,031 $108,000
Q1 2024

May 06, 2024

SELL
$6.35 - $9.39 $2,679 - $3,962
-422 Reduced 2.05%
20,176 $141,000
Q4 2023

Feb 13, 2024

SELL
$5.59 - $9.55 $5,249 - $8,967
-939 Reduced 4.36%
20,598 $182,000
Q3 2023

Nov 07, 2023

BUY
$9.5 - $15.07 $58,444 - $92,710
6,152 Added 39.99%
21,537 $205,000
Q2 2023

Aug 02, 2023

BUY
$11.41 - $17.05 $3,046 - $4,552
267 Added 1.77%
15,385 $225,000
Q1 2023

May 10, 2023

BUY
$11.21 - $21.11 $12,398 - $23,347
1,106 Added 7.89%
15,118 $185,000
Q4 2022

Feb 07, 2023

BUY
$15.2 - $21.12 $212,982 - $295,933
14,012 New
14,012 $260,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $321M
More about PRME
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.